Bellevue Asset Management (Switzerland)’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.51M Hold
2015
Q3
$1.69M Buy
2015
Q2
$1.87M Sell
2015
Q1
$2.61M Buy